210 related articles for article (PubMed ID: 23454088)
1. Biochemical and biophysical changes underlie the mechanisms of basement membrane disruptions in a mouse model of dystroglycanopathy.
Zhang P; Yang Y; Candiello J; Thorn TL; Gray N; Halfter WM; Hu H
Matrix Biol; 2013 Apr; 32(3-4):196-207. PubMed ID: 23454088
[TBL] [Abstract][Full Text] [Related]
2. Retinal ectopias and mechanically weakened basement membrane in a mouse model of muscle-eye-brain (MEB) disease congenital muscular dystrophy.
Hu H; Candiello J; Zhang P; Ball SL; Cameron DA; Halfter W
Mol Vis; 2010 Jul; 16():1415-28. PubMed ID: 20680099
[TBL] [Abstract][Full Text] [Related]
3. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
[TBL] [Abstract][Full Text] [Related]
4. Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell-cell adhesion.
Noor SI; Hoffmann M; Rinis N; Bartels MF; Winterhalter PR; Hoelscher C; Hennig R; Himmelreich N; Thiel C; Ruppert T; Rapp E; Strahl S
J Biol Chem; 2021; 296():100433. PubMed ID: 33610554
[TBL] [Abstract][Full Text] [Related]
5. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy.
Goddeeris MM; Wu B; Venzke D; Yoshida-Moriguchi T; Saito F; Matsumura K; Moore SA; Campbell KP
Nature; 2013 Nov; 503(7474):136-40. PubMed ID: 24132234
[TBL] [Abstract][Full Text] [Related]
6. Reactive gliosis of astrocytes and Müller glial cells in retina of POMGnT1-deficient mice.
Takahashi H; Kanesaki H; Igarashi T; Kameya S; Yamaki K; Mizota A; Kudo A; Miyagoe-Suzuki Y; Takeda S; Takahashi H
Mol Cell Neurosci; 2011 Jun; 47(2):119-30. PubMed ID: 21447391
[TBL] [Abstract][Full Text] [Related]
7. FAK deficiency in cells contributing to the basal lamina results in cortical abnormalities resembling congenital muscular dystrophies.
Beggs HE; Schahin-Reed D; Zang K; Goebbels S; Nave KA; Gorski J; Jones KR; Sretavan D; Reichardt LF
Neuron; 2003 Oct; 40(3):501-14. PubMed ID: 14642275
[TBL] [Abstract][Full Text] [Related]
8. Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.
Kanagawa M; Michele DE; Satz JS; Barresi R; Kusano H; Sasaki T; Timpl R; Henry MD; Campbell KP
FEBS Lett; 2005 Aug; 579(21):4792-6. PubMed ID: 16098969
[TBL] [Abstract][Full Text] [Related]
9. Breaches of the pial basement membrane and disappearance of the glia limitans during development underlie the cortical lamination defect in the mouse model of muscle-eye-brain disease.
Hu H; Yang Y; Eade A; Xiong Y; Qi Y
J Comp Neurol; 2007 Mar; 501(1):168-83. PubMed ID: 17206611
[TBL] [Abstract][Full Text] [Related]
10. Alterations in basement membrane immunoreactivity of the diabetic retina in three diabetic mouse models.
Abari E; Kociok N; Hartmann U; Semkova I; Paulsson M; Lo A; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):763-75. PubMed ID: 23263623
[TBL] [Abstract][Full Text] [Related]
11. Expression of dystroglycan, fukutin and POMGnT1 during mouse cerebellar development.
Henion TR; Qu Q; Smith FI
Brain Res Mol Brain Res; 2003 Apr; 112(1-2):177-81. PubMed ID: 12670716
[TBL] [Abstract][Full Text] [Related]
12. Molecular interactions in the retinal basement membrane system: a proteomic approach.
Balasubramani M; Schreiber EM; Candiello J; Balasubramani GK; Kurtz J; Halfter W
Matrix Biol; 2010 Jul; 29(6):471-83. PubMed ID: 20403434
[TBL] [Abstract][Full Text] [Related]
13. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
Michele DE; Barresi R; Kanagawa M; Saito F; Cohn RD; Satz JS; Dollar J; Nishino I; Kelley RI; Somer H; Straub V; Mathews KD; Moore SA; Campbell KP
Nature; 2002 Jul; 418(6896):417-22. PubMed ID: 12140558
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy.
Yu M; He Y; Wang K; Zhang P; Zhang S; Hu H
Hum Gene Ther; 2013 Mar; 24(3):317-30. PubMed ID: 23379513
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
[TBL] [Abstract][Full Text] [Related]
17. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy.
Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP
Elife; 2023 Feb; 12():. PubMed ID: 36723429
[TBL] [Abstract][Full Text] [Related]
18. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular characterization of abnormal brain development in protein o-mannose N-acetylglucosaminyltransferase 1 knockout mice.
Liu J; Yang Y; Li X; Zhang P; Qi Y; Hu H
Methods Enzymol; 2010; 479():353-66. PubMed ID: 20816176
[TBL] [Abstract][Full Text] [Related]
20. Pikachurin interaction with dystroglycan is diminished by defective O-mannosyl glycosylation in congenital muscular dystrophy models and rescued by LARGE overexpression.
Hu H; Li J; Zhang Z; Yu M
Neurosci Lett; 2011 Feb; 489(1):10-5. PubMed ID: 21129441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
